Acute inflammation is one of biology's most elegant defense mechanisms. Chronic low-grade inflammation is something entirely different: a sustained, smoldering state of immune activation that damages tissue, accelerates cellular aging, and underlies virtually every major age-related disease. Understanding inflammaging is essential to any serious longevity strategy.
The term inflammaging was coined by Claudio Franceschi in 2000 to describe a consistent observation in immunological studies of centenarians: aging is accompanied by a progressive increase in systemic inflammatory tone, reflected in elevated circulating levels of pro-inflammatory cytokines even in the absence of acute illness. This low-grade, chronic, sterile inflammation is not merely a consequence of aging - it is a driver of the aging process itself, accelerating cellular damage, impairing tissue repair, and creating the immunological environment in which age-related disease flourishes.1
Senescent cells and the SASP are the most direct and mechanistically well-understood source. As senescent cells accumulate throughout the body with age, their SASP secretome - comprising IL-6, IL-8, TNF-alpha, MCP-1, and dozens of other mediators - creates a persistent local and systemic inflammatory signal. The SASP also activates NF-kB in neighboring cells, propagating the inflammatory signal beyond the senescent cell itself.2
Gut barrier dysfunction - increased intestinal permeability allowing bacterial LPS to enter systemic circulation - is a potent and underappreciated source. LPS is one of the most potent activators of the innate immune TLR4 signaling pathway known. Elevated circulating LPS levels drive chronic NF-kB activation and macrophage activation throughout the body. This explains why gut microbiome diversity and butyrate-producing bacteria - which maintain tight junction integrity - are so consistently associated with reduced systemic inflammation and healthier aging.3
Dysfunctional mitochondria release DAMPs including mitochondrial DNA that activate innate immune pattern recognition receptors, triggering inflammatory cascades. Damaged mitochondria not only produce excessive ROS but actively signal danger to the immune system.4
"Inflammation is not a symptom of aging. It is one of its primary engines. Cooling it down is not a side task in a longevity protocol - it is central."
Dr. Claudio Franceschi, University of Bologna, who coined the term inflammagingInflammation promotes senescence: Inflammatory cytokines (particularly IL-1 and TNF-alpha) can directly induce cellular senescence in healthy cells - called paracrine senescence. This means that senescent cells, through their SASP, can convert neighboring healthy cells into senescent cells, creating an expanding cycle of cellular dysfunction. Inflammation impairs autophagy: NF-kB activation suppresses autophagy, reducing the cell's ability to clear damaged proteins and organelles. This allows accumulation of cellular debris that further activates inflammasome pathways, producing more inflammation. Inflammation damages telomeres: Oxidative stress from inflammatory ROS production directly damages telomeric DNA, accelerating telomere shortening and triggering replicative senescence prematurely.5
Exercise is the most potent anti-inflammatory intervention available. Aerobic exercise acutely elevates muscle-derived IL-6 (which in the post-exercise context has anti-inflammatory effects) and chronically reduces circulating CRP and TNF-alpha at rest. Regular exercise also reduces visceral adiposity, improves gut microbiome diversity, and enhances immune regulatory function - addressing multiple inflammaging sources simultaneously.6
Gut microbiome optimization - through dietary fiber diversity, fermented foods, and prebiotics - reduces gut permeability and LPS translocation, directly addressing one of the primary sources of systemic inflammaging. The 2021 Stanford trial showed a high-fermented-food diet reduced 19 inflammatory markers more effectively than a high-fiber diet alone. Senolytics by clearing senescent cells directly reduce the SASP-driven component of inflammaging. Omega-3 fatty acids (EPA specifically) reduce the production of pro-inflammatory eicosanoids from arachidonic acid and activate specialized pro-resolving mediators that actively terminate inflammatory responses.
